These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6373316)

  • 41. Glycaemic control on nutritional support: finding stability in unstable times.
    Gillard P; Charleer S; Mathieu C
    Lancet Diabetes Endocrinol; 2019 May; 7(5):330-331. PubMed ID: 30935871
    [No Abstract]   [Full Text] [Related]  

  • 42. Metabolic effects of intensified insulin therapy.
    Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
    Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I; Ortego J; Valencia I; García-Palacios MV; Aguilar-Diosdado M
    Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):378-85. PubMed ID: 19629931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of a glucose-controlled insulin infusion system in children and adolescents with insulin-dependent diabetes.
    Golden MP; Myers GL; Tanner SM; Marrero DG; Charles MA
    Pediatrics; 1982 Jul; 70(1):36-42. PubMed ID: 7088631
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Improvement of artificial endocrine pancreas (Biostator; GCIIS) performance combining feedback controlled insulin administration with a pre-programmed insulin infusion.
    Calabrese G; Bueti A; Zega G; Giombolini A; Bellomo G; Antonella MA; Massi-Benedetti M; Brunetti P
    Horm Metab Res; 1982 Oct; 14(10):505-7. PubMed ID: 6757081
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Insulin needs of insulin-dependent diabetics during biostator control and subcutaneous use of insulin].
    Petkova M; Khristov V; Tsanev A
    Vutr Boles; 1990; 29(1):74-7. PubMed ID: 2204207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Individualized insulin therapy in children and adolescents with type 1 diabetes.
    Becker D
    Acta Paediatr Suppl; 1998 Oct; 425():20-4. PubMed ID: 9822189
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long-term improvement in metabolic control of unstable type I diabetes by s.c. insulin injection patterns based on the dose profiles required by bed-side artificial beta-cell.
    Bombor H; Bruns W; Ratzmann KP; Jutzi E; Albrecht G; Michaelis D; Fischer U
    Exp Clin Endocrinol; 1984 Apr; 83(2):143-51. PubMed ID: 6373316
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subcutaneous absorption of insulin in insulin-dependent diabetic patients. Influence of species, physico-chemical properties of insulin and physiological factors.
    Hildebrandt P
    Dan Med Bull; 1991 Aug; 38(4):337-46. PubMed ID: 1914533
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Risks and side effects of intensified insulin therapy].
    Honegger R; Spinas GA
    Wien Med Wochenschr; 1997; 147(9):226-30. PubMed ID: 9281237
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.